On this page you'll find 10+ example sentences with Lecanemab. Discover the meaning, how to use the word correctly in a sentence.
Lecanemab in a sentence
Lecanemab meaning
A drug for the treatment of Alzheimer's disease.
Using Lecanemab
- The main meaning on this page is: A drug for the treatment of Alzheimer's disease.
- In the example corpus, lecanemab often appears in combinations such as: lecanemab in, that lecanemab, lecanemab is.
Context around Lecanemab
- Average sentence length in these examples: 27.1 words
- Position in the sentence: 7 start, 4 middle, 1 end
- Sentence types: 12 statements, 0 questions, 0 exclamations
Corpus analysis for Lecanemab
- In this selection, "lecanemab" usually appears near the start of the sentence. The average example has 27.1 words, and this corpus slice is mostly made up of statements.
- Around the word, developing, drug, cure, change, treatment and last stand out and add context to how "lecanemab" is used.
- Recognizable usage signals include a cure lecanemab is an and aducanumab and lecanemab change disease. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "lecanemab" sits close to words such as aadi, aakash and aayush, which helps place it inside the broader word index.
Example types with lecanemab
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
For example, the most recent anti-Alzheimer’s drug to win FDA approval is lecanemab. (15 words)
Biogen is developing lecanemab in partnership with Eisai, with all research, sales, and marketing costs to be shared equally between the two companies. (23 words)
While lecanemab is being administered to all participants, half of them are also given the new drug and the other half a placebo. (23 words)
Since U.C.S.F. started administering lecanemab last fall, the hospital has treated a few dozen patients with it, with roughly 60 percent of people who met the screening criteria ultimately being approved by the panel. (37 words)
Because immunotherapies like aducanumab and lecanemab change disease biology, “there are a number of different studies — phase 2 and 3 studies — that show it makes a difference in cognition and function,” Foster said. (33 words)
This application is based on the results of the Phase 3 Clarity AD study and the Phase clinical study, which demonstrated that lecanemab treatment showed a reduction of clinical decline in early AD. (33 words)
Example sentences (12)
Because immunotherapies like aducanumab and lecanemab change disease biology, “there are a number of different studies — phase 2 and 3 studies — that show it makes a difference in cognition and function,” Foster said.
Biogen is developing lecanemab in partnership with Eisai, with all research, sales, and marketing costs to be shared equally between the two companies.
But their deaths occurred after that phase of the trial, when they were knowingly being treated with lecanemab in what’s known as an open-label extension study.
Even lecanemab, the new amyloid-targeting Alzheimer’s medication that towards the end of 2022, only offers marginal benefits in slowing down memory loss.
For example, the most recent anti-Alzheimer’s drug to win FDA approval is lecanemab.
The drug, Lecanemab, will be sold under the name Leqembi and is a monoclonal antibody infusion administered every two weeks for patients with mild cognitive impairment.
This application is based on the results of the Phase 3 Clarity AD study and the Phase clinical study, which demonstrated that lecanemab treatment showed a reduction of clinical decline in early AD.
Alzheimer's Research UK's chief executive, Hilary Evans-Newton, also sees the partial approval as positive: "Although not a cure, lecanemab is an important step forward," she also told SMC.
But the National Institute for Health and Care Excellence (Nice) said the benefits of lecanemab were “just too small to justify the significant cost to the NHS”.
Simmons said it was likely that lecanemab was the first of other, similar treatments so it was important to begin work on rolling them out.
Since U.C.S.F. started administering lecanemab last fall, the hospital has treated a few dozen patients with it, with roughly 60 percent of people who met the screening criteria ultimately being approved by the panel.
While lecanemab is being administered to all participants, half of them are also given the new drug and the other half a placebo.
Common combinations with lecanemab
These word pairs occur most frequently in English texts:
- lecanemab in 2×
- that lecanemab 2×
- lecanemab is 2×